AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33337659 — intervention group
Group type: COMPARATOR
Intervention: Placebo b.i.d.
Number of subjects: 620
Study 35543938 — intervention group
Group type: EXPERIMENTAL
Intervention: Panlong needling at Jiaji (EX‐B 2) combined with western medication
Number of subjects: 98
Study 35543938 — intervention group
Group type: COMPARATOR
Intervention: Western medication alone (levodopa and benserazide hydrochloride tablets)
Number of subjects: 98
Study 32975296 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard dressing, elastic compression, and REAC TO-RPR treatment
Number of subjects: 30
Study 32975296 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard dressing and REAC TO-RPR treatment
Number of subjects: 30
Study 32975296 — intervention group
Group type: COMPARATOR
Intervention: Standard dressing and elastic compression
Number of subjects: 30
Study 35786344 — intervention group
Group type: EXPERIMENTAL
Intervention: Nano-curcumin (80 mg/day)
Number of subjects: 44
Study 35786344 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study 32371165 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-TNF therapy
Number of subjects: 2257
Study 33109658 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual care plus up to £400 financial incentives
Number of subjects: 0
Study 33109658 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study 35414414 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypochlorous Acid (HCOL)
Number of subjects: 60
Study 35414414 — intervention group
Group type: COMPARATOR
Intervention: Povidone Iodine (PI)
Number of subjects: 60
Study 32051454 — intervention group
Group type: EXPERIMENTAL
Intervention: Follow-up diagnostic colonoscopy
Number of subjects: 2018
Study 32051454 — intervention group
Group type: EXPERIMENTAL
Intervention: Demographic characteristics (younger, Hispanic, Spanish-speaking, zero or one Charlson comorbidity)
Number of subjects: 2018
Study 32051454 — intervention group
Group type: EXPERIMENTAL
Intervention: Neighborhood-level predictors
Number of subjects: 2018
Study 35749710 — intervention group
Group type: EXPERIMENTAL
Intervention: Cannabidiol (CBD) at doses of 75-300 mg
Number of subjects: 18
Study 35749710 — intervention group
Group type: COMPARATOR
Intervention: Placebo capsules
Number of subjects: 18
Study 33691576 — intervention group
Group type: EXPERIMENTAL
Intervention: CRMR treatment (n = 19)
Number of subjects: 38
Study 33691576 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 19)
Number of subjects: 38
Study 34695451 — intervention group
Group type: EXPERIMENTAL
Intervention: M1-tDCS
Number of subjects: 26
Study 34695451 — intervention group
Group type: EXPERIMENTAL
Intervention: DLPFC-tDCS
Number of subjects: 26
Study 34695451 — intervention group
Group type: COMPARATOR
Intervention: Sham-tDCS
Number of subjects: 26
Study 33606045 — intervention group
Group type: EXPERIMENTAL
Intervention: Alendronate (ALN) 70 mg/week
Number of subjects: 175
Study 33606045 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 175
Study 32678054 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (DEX)
Number of subjects: 83
Study 32678054 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 83
Study 36200736 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-tracheostomy intervention group
Number of subjects: 128
Study 36200736 — intervention group
Group type: COMPARATOR
Intervention: Non-tracheostomy control group
Number of subjects: 128
Study 36200736 — intervention group
Group type: EXPERIMENTAL
Intervention: Tracheostomy intervention group
Number of subjects: 128
Study 36200736 — intervention group
Group type: COMPARATOR
Intervention: Tracheostomy control group
Number of subjects: 128
Study 35643729 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-HIFU MRI Likert scale
Number of subjects: 110
Study 35643729 — intervention group
Group type: EXPERIMENTAL
Intervention: High suspicion on post-HIFU MRI
Number of subjects: 110
Study 35643729 — intervention group
Group type: EXPERIMENTAL
Intervention: More cancer-positive cores on initial biopsy
Number of subjects: 110
Study 35810836 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity physical exercise (20-minute indoor cycling session at 80-90% HRmax)
Number of subjects: 19
Study 35810836 — intervention group
Group type: COMPARATOR
Intervention: Control group (no physical exercise)
Number of subjects: 19
Study 33127585 — intervention group
Group type: EXPERIMENTAL
Intervention: Possession of an analgesic cream
Number of subjects: 127
Study 33127585 — intervention group
Group type: COMPARATOR
Intervention: Possession of an anti-itch cream (pain-irrelevant control object)
Number of subjects: 127
Study 33127585 — intervention group
Group type: EXPERIMENTAL
Intervention: Prior pain experience (PP condition)
Number of subjects: 127
Study 32053027 — intervention group
Group type: EXPERIMENTAL
Intervention: EC board games (experimental group)
Number of subjects: 177
Study 32053027 — intervention group
Group type: COMPARATOR
Intervention: Off-the-shelf board games (control group)
Number of subjects: 177
Study 33210287 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone
Number of subjects: 429
Study 33210287 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 429
Study 33210287 — intervention group
Group type: COMPARATOR
Intervention: Testosterone and Placebo
Number of subjects: 429
Study 32004243 — intervention group
Group type: EXPERIMENTAL
Intervention: Group A: clinical evaluation and ECG every 3 months, echocardiography every 6 months
Number of subjects: 436
Study 32004243 — intervention group
Group type: COMPARATOR
Intervention: Group B: clinical evaluation and ECG every 3 months only
Number of subjects: 436
Study 35844123 — intervention group
Group type: EXPERIMENTAL
Intervention: NOSES group (using the Cai tube)
Number of subjects: 60
Study 35844123 — intervention group
Group type: COMPARATOR
Intervention: CL group (conventional laparoscopic surgery)
Number of subjects: 60
Study 34607820 — intervention group
Group type: EXPERIMENTAL
Intervention: Niraparib plus dostarlimab
Number of subjects: 427
Study 34607820 — intervention group
Group type: COMPARATOR
Intervention: Physician's choice chemotherapy
Number of subjects: 427
Study 32510984 — intervention group
Group type: EXPERIMENTAL
Intervention: Genotype-guided dosing group
Number of subjects: 660
Study 32510984 — intervention group
Group type: EXPERIMENTAL
Intervention: Warfarin normal sensitivity group (subgroup of genotype-guided dosing)
Number of subjects: 660
Study 32510984 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard dosing)
Number of subjects: 660
Study 33386336 — intervention group
Group type: EXPERIMENTAL
Intervention: Sensor-based inhaler monitoring
Number of subjects: 252
Study 33386336 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 252
Study 32241376 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 36314486 — intervention group
Group type: EXPERIMENTAL
Intervention: New Forest Parenting Programme (NFPP)
Number of subjects: 93
Study 36314486 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 93
Study 33095999 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise (AE)
Number of subjects: 26
Study 33095999 — intervention group
Group type: EXPERIMENTAL
Intervention: tDCS (1 mA anodal stimulation to the lower limb motor cortex)
Number of subjects: 26
Study 33095999 — intervention group
Group type: EXPERIMENTAL
Intervention: AE+tDCS
Number of subjects: 26
Study 33095999 — intervention group
Group type: COMPARATOR
Intervention: Control (AE or tDCS administered alone)
Number of subjects: 26
Study 32815806 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised physiotherapy
Number of subjects: 80
Study 32815806 — intervention group
Group type: COMPARATOR
Intervention: Home exercises only
Number of subjects: 80
Study 35831626 — intervention group
Group type: EXPERIMENTAL
Intervention: PHS (spray) + tooth brushing
Number of subjects: 64
Study 35831626 — intervention group
Group type: COMPARATOR
Intervention: Tooth brushing
Number of subjects: 64
Study 35831626 — intervention group
Group type: EXPERIMENTAL
Intervention: PHS (immersion) + tooth brushing
Number of subjects: 64
Study 35831626 — intervention group
Group type: EXPERIMENTAL
Intervention: PHS (spray)
Number of subjects: 64
Study 35831626 — intervention group
Group type: EXPERIMENTAL
Intervention: PHS (immersion)
Number of subjects: 64
Study 34172602 — intervention group
Group type: EXPERIMENTAL
Intervention: 18F‐FDG PET imaging biomarkers
Number of subjects: 31
Study 34172602 — intervention group
Group type: EXPERIMENTAL
Intervention: LASSO logistic regression models
Number of subjects: 31
Study 34172602 — intervention group
Group type: EXPERIMENTAL
Intervention: Response classification models
Number of subjects: 31
Study 34172602 — intervention group
Group type: EXPERIMENTAL
Intervention: Interobserver variability of PET contours
Number of subjects: 31
Study 34172602 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraobserver variability between reconstructions
Number of subjects: 31
Study 34172602 — intervention group
Group type: EXPERIMENTAL
Intervention: Objective midtreatment PET response assessment
Number of subjects: 31
Study 35194646 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual physical therapy including desensitization maneuvers of the central nervous system
Number of subjects: 104
Study 35194646 — intervention group
Group type: COMPARATOR
Intervention: Surgery
Number of subjects: 104
Study 35194646 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual physical therapy
Number of subjects: 104
Study 34211263 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxymetazoline 0.1%
Number of subjects: 304
Study 35835925 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebulized hyaluronic acid (HA)
Number of subjects: 48
Study 35835925 — intervention group
Group type: COMPARATOR
Intervention: Control (no nebulized HA)
Number of subjects: 48
Study 32822053 — intervention group
Group type: EXPERIMENTAL
Intervention: Software Package 1
Number of subjects: 81
Study 32822053 — intervention group
Group type: COMPARATOR
Intervention: Software Package 2
Number of subjects: 81
Study 34003156 — intervention group
Group type: EXPERIMENTAL
Intervention: Peripheral neurectomy surgery
Number of subjects: 26
Study 34003156 — intervention group
Group type: COMPARATOR
Intervention: Standard medical treatment
Number of subjects: 26
Study 35403841 — intervention group
Group type: EXPERIMENTAL
Intervention: Nivolumab plus platinum-based chemotherapy
Number of subjects: 0
Study 35403841 — intervention group
Group type: COMPARATOR
Intervention: Platinum-based chemotherapy alone
Number of subjects: 0
Study 33619968 — intervention group
Group type: EXPERIMENTAL
Intervention: Cerebral Embolic Protection Devices (EPDs)
Number of subjects: 123186
Study 32184135 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise therapy
Number of subjects: 140
Study 32184135 — intervention group
Group type: COMPARATOR
Intervention: Arthroscopic partial meniscectomy
Number of subjects: 140
Study 34857494 — intervention group
Group type: EXPERIMENTAL
Intervention: IV antimicrobial treatment at home only
Number of subjects: 0
Study 34857494 — intervention group
Group type: EXPERIMENTAL
Intervention: IV antimicrobial treatment both at home and in hospital
Number of subjects: 0
Study 34857494 — intervention group
Group type: EXPERIMENTAL
Intervention: IV antimicrobial treatment in hospital only
Number of subjects: 0
Study 33337592 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic training
Number of subjects: 119
Study 33337592 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 119
Study 35164976 — intervention group
Group type: EXPERIMENTAL
Intervention: Transoral laser surgery (TLS)
Number of subjects: 56
Study 35164976 — intervention group
Group type: COMPARATOR
Intervention: Radiation therapy (RT)
Number of subjects: 56
Study 34018861 — intervention group
Group type: EXPERIMENTAL
Intervention: Atezolizumab plus nab-paclitaxel
Number of subjects: 902
Study 34018861 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus nab-paclitaxel
Number of subjects: 902
Study 32561663 — intervention group
Group type: EXPERIMENTAL
Intervention: Apalutamide (240 mg once daily)
Number of subjects: 1207
Study 32561663 — intervention group
Group type: EXPERIMENTAL
Intervention: Apalutamide (average daily dose reduced to 209 mg)
Number of subjects: 1207
Study 32561663 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1207
Study 34859616 — intervention group
Group type: EXPERIMENTAL
Intervention: Health professional training and application of a digital screening tool
Number of subjects: 65
Study 32189088 — intervention group
Group type: EXPERIMENTAL
Intervention: Active Surveillance
Number of subjects: 130
Study 32189088 — intervention group
Group type: COMPARATOR
Intervention: Radical Prostatectomy
Number of subjects: 130
Study 33059293 — intervention group
Group type: EXPERIMENTAL
Intervention: AMZ001 once daily (QD)
Number of subjects: 444
Study 33059293 — intervention group
Group type: EXPERIMENTAL
Intervention: AMZ001 twice daily (BID)
Number of subjects: 444
Study 33059293 — intervention group
Group type: EXPERIMENTAL
Intervention: AMZ001 BID
Number of subjects: 444
Study 33059293 — intervention group
Group type: EXPERIMENTAL
Intervention: AMZ001 QD
Number of subjects: 444
Study 33059293 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 444
Study 36380045 — intervention group
Group type: EXPERIMENTAL
Intervention: Somapacitan
Number of subjects: 120
Study 36380045 — intervention group
Group type: COMPARATOR
Intervention: Daily GH
Number of subjects: 120
Study 32007324 — intervention group
Group type: EXPERIMENTAL
Intervention: 6MWT30 (30-meter track)
Number of subjects: 30
Study 32007324 — intervention group
Group type: COMPARATOR
Intervention: 6MWT20 (20-meter track)
Number of subjects: 30
Study 32007324 — intervention group
Group type: EXPERIMENTAL
Intervention: 6MWT30 (for patients walking ≥430 m)
Number of subjects: 30
Study 32124144 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated oral language and listening comprehension intervention, delivered in small groups of 3 or 4, 4 days per week for 20 weeks
Number of subjects: 43
Study 32124144 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 43
Study 32658089 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational gaming activity
Number of subjects: 844
Study 32658089 — intervention group
Group type: COMPARATOR
Intervention: Control group (no educational gaming)
Number of subjects: 844
Study 32620543 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mL/kg up to 1000 mL of normal saline (fluid bolus group)
Number of subjects: 58
Study 32620543 — intervention group
Group type: COMPARATOR
Intervention: 5 mL of normal saline (control group)
Number of subjects: 58
Study 32620543 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluid bolus group
Number of subjects: 58
Study 32620543 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 58
Study 36372660 — intervention group
Group type: EXPERIMENTAL
Intervention: eHealth behavior change support (BCS) program delivered on Facebook and texts for 10 weeks
Number of subjects: 0
Study 36372660 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study 33993331 — intervention group
Group type: EXPERIMENTAL
Intervention: 2‐mSv CT (n = 1535)
Number of subjects: 3074
Study 33993331 — intervention group
Group type: COMPARATOR
Intervention: Conventional-dose CT (CDCT, n = 1539)
Number of subjects: 3074
Study 33993331 — intervention group
Group type: EXPERIMENTAL
Intervention: 2‐mSv CT
Number of subjects: 3074
Study 33993331 — intervention group
Group type: COMPARATOR
Intervention: Conventional-dose CT (CDCT)
Number of subjects: 3074
Study 34448856 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidomain lifestyle intervention (healthy diet, physical, social and cognitive activity, management of cardiovascular risks)
Number of subjects: 27
Study 34448856 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthcare professionals' perceptions of the lifestyle intervention
Number of subjects: 27
Study 34448856 — intervention group
Group type: EXPERIMENTAL
Intervention: Education on dementia prevention
Number of subjects: 27
Study 34448856 — intervention group
Group type: EXPERIMENTAL
Intervention: Coordination of work and adequate resources
Number of subjects: 27
Study 34448856 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiprofessional collaboration
Number of subjects: 27
Study 32853117 — intervention group
Group type: EXPERIMENTAL
Intervention: Pattern discrimination task at 3500 Hz CF
Number of subjects: 2
Study 32853117 — intervention group
Group type: EXPERIMENTAL
Intervention: Pattern discrimination task at 750 Hz CF
Number of subjects: 2
Study 32853117 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective attention to frequency with instruction
Number of subjects: 2
Study 32853117 — intervention group
Group type: EXPERIMENTAL
Intervention: Divided attention, assessing inherent frequency biases
Number of subjects: 2
Study 32853117 — intervention group
Group type: COMPARATOR
Intervention: Pattern discrimination task in quiet
Number of subjects: 2
Study 36121865 — intervention group
Group type: EXPERIMENTAL
Intervention: CSB-MNP-A (multiple micronutrients containing zinc)
Number of subjects: 346
Study 36121865 — intervention group
Group type: COMPARATOR
Intervention: Control (standard CSB fortified with multiple micronutrients)
Number of subjects: 346
Study 36121865 — intervention group
Group type: EXPERIMENTAL
Intervention: CSB-MNP-B (multiple micronutrients without zinc)
Number of subjects: 346
Study 36121865 — intervention group
Group type: EXPERIMENTAL
Intervention: CSB-MNP-C (zinc only)
Number of subjects: 346
Study 32150432 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral Inhibition System (BIS)
Number of subjects: 328
Study 32150432 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral Activation System (BAS)
Number of subjects: 328
Study 32777789 — intervention group
Group type: EXPERIMENTAL
Intervention: Vismodegib
Number of subjects: 0
Study 32777789 — intervention group
Group type: EXPERIMENTAL
Intervention: Sonidegib
Number of subjects: 0
Study 37074807 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 g mannitol
Number of subjects: 0
Study 37074807 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 g mannitol
Number of subjects: 0
Study 37074807 — intervention group
Group type: EXPERIMENTAL
Intervention: 150 g mannitol
Number of subjects: 0
Study 33904329 — intervention group
Group type: EXPERIMENTAL
Intervention: Inoculation with L. pseudotheobromae
Number of subjects: 9
Study 33904329 — intervention group
Group type: EXPERIMENTAL
Intervention: Inoculation with L. theobromae
Number of subjects: 9
Study 33904329 — intervention group
Group type: COMPARATOR
Intervention: Control group (sterile PDA plugs)
Number of subjects: 9
Study 36369247 — intervention group
Group type: EXPERIMENTAL
Intervention: Baduanjin exercise (BDJ)
Number of subjects: 98
Study 36369247 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic training (AT)
Number of subjects: 98
Study 36369247 — intervention group
Group type: COMPARATOR
Intervention: Control group (no exercise)
Number of subjects: 98
Study 33002684 — intervention group
Group type: EXPERIMENTAL
Intervention: PoMeT (Positive Memory Training)
Number of subjects: 100
Study 33002684 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 100
Study 36288470 — intervention group
Group type: EXPERIMENTAL
Intervention: mHealth intervention
Number of subjects: 74
Study 36288470 — intervention group
Group type: EXPERIMENTAL
Intervention: mHealth plus intervention (includes nurse practitioner and community health worker)
Number of subjects: 74
Study 36288470 — intervention group
Group type: COMPARATOR
Intervention: Enhanced usual care (control group)
Number of subjects: 74
Study 34768093 — intervention group
Group type: EXPERIMENTAL
Intervention: Pitch-shift stimuli during vocalization of a steady speech vowel sound /a/
Number of subjects: 34
Study 34768093 — intervention group
Group type: EXPERIMENTAL
Intervention: Pitch-shift stimuli during listening to playback of self‐produced vowel vocalizations
Number of subjects: 34
Study 34768093 — intervention group
Group type: COMPARATOR
Intervention: No pitch-shift stimuli during vocalization and listening tasks (control condition)
Number of subjects: 34
Study 34648235 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided intervention (n=142) with adherence-focused guidance
Number of subjects: 576
Study 34648235 — intervention group
Group type: EXPERIMENTAL
Intervention: Unguided intervention (n=146) without guidance
Number of subjects: 576
Study 34648235 — intervention group
Group type: COMPARATOR
Intervention: Waiting-list control (n=144)
Number of subjects: 576
Study 32039957 — intervention group
Group type: EXPERIMENTAL
Intervention: TO (anchorless technique)
Number of subjects: 166
Study 32039957 — intervention group
Group type: COMPARATOR
Intervention: TOE (anchored technique)
Number of subjects: 166
Study 35164831 — intervention group
Group type: EXPERIMENTAL
Intervention: Erector spinae plane block (ESPB)
Number of subjects: 40
Study 35164831 — intervention group
Group type: COMPARATOR
Intervention: Thoracic paravertebral block (TPVB)
Number of subjects: 40
Study 32059687 — intervention group
Group type: EXPERIMENTAL
Intervention: HI-FIVES intervention
Number of subjects: 241
Study 32059687 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 241
Study 33998349 — intervention group
Group type: EXPERIMENTAL
Intervention: Peripheral cannulation
Number of subjects: 44
Study 33998349 — intervention group
Group type: COMPARATOR
Intervention: Central cannulation
Number of subjects: 44
Study 34656656 — intervention group
Group type: EXPERIMENTAL
Intervention: AI-based diagnostic-support software (dentalXrai Pro)
Number of subjects: 22
Study 34656656 — intervention group
Group type: COMPARATOR
Intervention: No AI support
Number of subjects: 22
Study 34656656 — intervention group
Group type: EXPERIMENTAL
Intervention: AI-based diagnostic-support software
Number of subjects: 22
Study 35522660 — intervention group
Group type: EXPERIMENTAL
Intervention: Voice activated technology
Number of subjects: 0
Study 35522660 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (SOC)
Number of subjects: 0
Study 32823839 — intervention group
Group type: EXPERIMENTAL
Intervention: Animal-Assisted Therapy (AAT) with a therapy dog
Number of subjects: 46
Study 32823839 — intervention group
Group type: COMPARATOR
Intervention: Physiotherapy (Control Group)
Number of subjects: 46
Study 33200892 — intervention group
Group type: EXPERIMENTAL
Intervention: Sotagliflozin
Number of subjects: 1222
Study 33200892 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1222
Study 36098051 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin
Number of subjects: 5988
Study 36098051 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5988